These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17033797)

  • 1. The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms.
    Volante M; Rindi G; Papotti M
    Virchows Arch; 2006 Nov; 449(5):499-506. PubMed ID: 17033797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data.
    Righi L; Volante M; Rapa I; Scagliotti GV; Papotti M
    Virchows Arch; 2007 Aug; 451 Suppl 1():S51-9. PubMed ID: 17684766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, characterization and classification of endocrine tumours.
    Wilander E; Grimelius L
    Zentralbl Pathol; 1993 Jun; 139(2):95-100. PubMed ID: 7690247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker".
    Abrahamsson PA; Falkmer S; Fält K; Grimelius L
    Pathol Res Pract; 1989 Sep; 185(3):373-80. PubMed ID: 2813190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuro-endocrine tumours--their origin and classification.
    Cohen RJ
    S Afr J Surg; 1992 Jun; 30(2):34-8. PubMed ID: 1519120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
    Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroendocrine system and its tumors].
    Schulz HJ; Ladhoff A
    Zentralbl Pathol; 1993 Jun; 139(2):101-6. PubMed ID: 8103675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.
    Visscher DW; Zarbo RJ; Trojanowski JQ; Sakr W; Crissman JD
    Mod Pathol; 1990 Jul; 3(4):508-12. PubMed ID: 2170973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms.
    Volante M; Righi L; Asioli S; Bussolati G; Papotti M
    Virchows Arch; 2007 Aug; 451 Suppl 1():S61-9. PubMed ID: 17684764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncocytic lesions of the neuroendocrine system.
    Baloch ZW; LiVolsi VA
    Semin Diagn Pathol; 1999 May; 16(2):190-9. PubMed ID: 10452583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine cells in pancreatic duct adenocarcinoma: an immunohistochemical study.
    Linder S; Myrvold K; Falkmer UG; Qvigstad G; Waldum HL; Falkmer SE
    J Exp Clin Cancer Res; 2006 Jun; 25(2):213-21. PubMed ID: 16918133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between neovascularisation and neuroendocrine differentiation in prostatic carcinoma.
    Grobholz R; Bohrer MH; Siegsmund M; Jünemann KP; Bleyl U; Woenckhaus M
    Pathol Res Pract; 2000; 196(5):277-84. PubMed ID: 10834383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroendocrine tumors].
    Caillou B; Tartour E; Schlumberger M
    Rev Prat; 1992 Apr; 42(7):839-43. PubMed ID: 1604203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
    Bonkhoff H; Fixemer T
    Urologe A; 2004 Jul; 43(7):836-42. PubMed ID: 15048555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mixed endocrine tumors].
    Hervieu V; Scoazec JY
    Ann Pathol; 2005 Dec; 25(6):511-28. PubMed ID: 16735976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.
    Fixemer T; Remberger K; Bonkhoff H
    Prostate; 2002 Oct; 53(2):118-23. PubMed ID: 12242726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
    di Sant'Agnese PA
    Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histopathology of neuroendocrine tumors].
    Saint-André JP; Dupré F; Chenue F; Guyétant S
    Ann Endocrinol (Paris); 1997; 58(2):101-11. PubMed ID: 9239228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.